CliffBio
small molecule

LYSODREN

MITOTANE

Loss of exclusivity—loss of exclusivity
CompanyEsteve →See this company's full patent-cliff portfolio

Drug detail

Brand nameLYSODREN
Active ingredientMITOTANE
Strength500MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusRX

More from Esteve

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LYSODREN patent cliff — loss of exclusivity — | CliffBio